These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38700303)

  • 21. Satellite Epidemic of Covid-19 Associated Mucormycosis in India: A Multi-Site Observational Study.
    Satija A; Anand T; Mukherjee A; Velamuri PS; Singh KJ; Das M; Josten K; Keche AY; Nagarkar NM; Gupta P; Himanshu D; Mistry SN; Patel JD; Rao P; Rohatgi S; Ghosh S; Hazra A; Kindo AJ; Annamalai R; Rudramurthy SM; Singh MP; Shameem M; Fatima N; Khambholja JR; Parikh S; Madkaikar M; Pradhan VD; Bhargava A; Mehata R; Arora RD; Tigga R; Banerjee G; Sonkar V; Malhotra HS; Kumar N; Patil R; Raut CG; Bhattacharyya K; Arthur P; Somu L; Srikanth P; Shah PB; Panda NK; Sharma D; Hasan W; Ahmed A; Bathla M; Solanki S; Doshi H; Kanani Y; Patel N; Shah Z; Tembhurne AK; Rajguru C; Sankhe LR; Chavan SS; Yadav RM; Panda S
    Mycopathologia; 2023 Oct; 188(5):745-753. PubMed ID: 37490256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronavirus Disease, Diabetes and Glucocorticoid a Terrible Trio for Invasive Mucormycosis: An Observational Study from Northwest Rajasthan.
    Nehara HR; Kumawat S; Gupta J; Gupta G; Sirohi P; Ih S; Gupta B
    J Assoc Physicians India; 2022 Dec; 69(12):11-12. PubMed ID: 35057586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.
    Sahu M; Shah M; Mallela VR; Kola VR; Boorugu HK; Punjani AAR; Kumar RV; Kumar S; Manusrut M; Kumar SCR; Rathod R; Babu DM; Gonuguntla HK; Yedlapati GK; Mallu GR; Reddy YS; Reddy VV; Alwala S; Bongu VK; Kamalesh A; Kumar RNK; Jaishetwar GS; Bagapally RS; Srinivas JS; Balasubramaniam A; Rajagopalan BK; Pullikanti B; Prakasham SP; Nimmala P; Nagaraju B; Sahoo PR;
    Infection; 2023 Apr; 51(2):407-416. PubMed ID: 35922704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
    Singh AK; Singh R; Joshi SR; Misra A
    Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucormycosis in the COVID-19 Environment: A Multifaceted Complication.
    Sharma R; Kumar P; Rauf A; Chaudhary A; Prajapati PK; Emran TB; Gonçalves Lima CM; Conte-Junior CA
    Front Cell Infect Microbiol; 2022; 12():937481. PubMed ID: 35923801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
    Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India.
    Singh K; Kumar S; Shastri S; Sudershan A; Mansotra V
    Immunogenetics; 2022 Apr; 74(2):197-206. PubMed ID: 34596728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes and Covid Associated Mucormucormycosis-A Cross Sectional Study in Kilpauk Medical College.
    Pradeepkumar V
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19-associated Mucormycosis: A clinico-epidemiological study.
    Chakravarty J; Gupta MK; Tilak R; Kumar R; Maurya RP; Kumar N; Aggarwal SK; S S; Sharma NK; Dhiman NK; Chaubey M; Singh V; Verma A; Banerjee T; Agrawal NK; Prasad RS
    J Diabetes Complications; 2022 Sep; 36(9):108284. PubMed ID: 35987108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
    Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
    Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrovascular Involvement in Mucormycosis in COVID-19 Pandemic.
    Kulkarni R; Pujari SS; Gupta D; Ojha P; Dhamne M; Bolegave V; Dhonde P; Soni A; Adwani S; Diwan A; Duberkar D; Batra D; Deshpande R; Aurangabadkar K; Palasdeokar N
    J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106231. PubMed ID: 34890962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of urgently initiated tele-prescription due to COVID-19 on glycemic control in patients with type 2 diabetes.
    Park SD; Kim NY; Jeon JH; Kim JG; Lee IK; Park KG; Choi YK
    Korean J Intern Med; 2021 Jul; 36(4):942-948. PubMed ID: 34092049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhinocerebral Mucormycosis: An Emerging Threat in the Era of COVID-19.
    Maassarani D; Bassil GF; Nehme M; Nassar A; Ghanime G; Sleiman Z
    Cureus; 2022 Aug; 14(8):e28057. PubMed ID: 36127989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 associated mucormycosis - An emerging threat.
    Chao CM; Lai CC; Yu WL
    J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping.
    Hussain S; Baxi H; Riad A; Klugarová J; Pokorná A; Slezáková S; Líčeník R; Najmi AK; Klugar M
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
    Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucormycosis and COVID-19: An epidemic within a pandemic in India.
    Selarka L; Sharma S; Saini D; Sharma S; Batra A; Waghmare VT; Dileep P; Patel S; Shah M; Parikh T; Darji P; Patel A; Goswami G; Shah A; Shah S; Lathiya H; Shah M; Sharma P; Chopra S; Gupta A; Jain N; Khan E; Sharma VK; Sharma AK; Chan ACY; Ong JJY
    Mycoses; 2021 Oct; 64(10):1253-1260. PubMed ID: 34255907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of Mucormycosis Cases During the Second Wave of COVID-19 in a Tertiary Care Institute in Western Rajasthan, India.
    Kumar A; Verma M; Hakim A; Sharma S; Meena R; Bhansali S
    Cureus; 2022 Mar; 14(3):e22973. PubMed ID: 35415040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the COVID-19 pandemic on the glycemic control, eating habits, and body compositions of people with diabetes mellitus: A retrospective longitudinal observational study.
    Sawada M; Ohkuma K; Aihara M; Doi S; Sekine R; Kaneko T; Iimuro S; Ichi I; Usami S; Ohe K; Yamauchi T; Kubota N
    J Diabetes Investig; 2023 Feb; 14(2):321-328. PubMed ID: 36346131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
    Kumar S; Kumar H; Mali M; Meena BL
    Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.